Accuray Incorporated's CEO to Speak at 31st Annual J.P. Morgan Healthcare Conference

  Accuray Incorporated's CEO to Speak at 31st Annual J.P. Morgan Healthcare
                                  Conference

PR Newswire

SUNNYVALE, Calif., Dec. 20, 2012

SUNNYVALE, Calif., Dec. 20, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq:
ARAY), the premier radiation oncology company, announced today that its
president and chief executive officer, Joshua H. Levine, is scheduled to
present at the J.P. Morgan Healthcare Conference in San Francisco on Monday,
January 7, 2013 at 9:00 a.m. PST/12:00 p.m. EST.

A live webcast of the presentations will be available online from the Investor
Relations page of the Company's website at http://www.accuray.com/investors.

The webcast replay of the presentation will begin approximately one hour after
the conclusion of the live presentation and will be available for
approximately 30 days.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the
premier radiation oncology company that develops, manufactures and sells
personalized, innovative treatment solutions that set the standard of care
with the aim of helping patients live longer, better lives. The Company's
leading-edge technologies – the CyberKnife and TomoTherapy Systems – are
designed to deliver radiosurgery, stereotactic body radiation therapy,
intensity modulated radiation therapy, image guided radiation therapy, and
adaptive radiation therapy. To date, 667 systems have been installed in
leading hospitals around the world. For more information, please visit
www.accuray.com.

SOURCE Accuray Incorporated

Website: http://www.accuray.com
Contact: Investor Contact: Tom Rathjen, Vice President, Investor Relations,
+1-408-789-4458, trathjen@accuray.com, or Media Contact: Stephanie Tomei,
Director, Corporate Communications, +1-408-789-4234, stomei@accuray.com
 
Press spacebar to pause and continue. Press esc to stop.